SOX2 and glioblastoma: Furthermore, western blot experiments (P < 0.05, Fig. 5d) were utilized to detect the protein expression, and Dazl knocked-down glioblastoma cell lines showed significantly reduced expression of stemness markers CD133, Oct4, Nanog, and Sox2, and no changes in the protein expression of beta-Catenin.